Have you used Kanjinti as a part of your HER2- treatment plan?

Are you currently, or have you previously, taken Kanjinti has been a part of your treatment plan?

Help others in the community by sharing your experience.

Kanjinti is used to treat certain people with metastatic breast cancer that is positive for the human epidermal growth factor receptor 2 (HER2+). You can read more about it here: https://advancedbreastcancer.net/treatment/kanjinti